A detailed history of Harbor Capital Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 11,427 shares of AMGN stock, worth $3.37 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
11,427
Previous 11,373 0.47%
Holding current value
$3.37 Million
Previous $3.55 Million 3.63%
% of portfolio
0.16%
Previous 0.27%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$309.38 - $337.38 $16,706 - $18,218
54 Added 0.47%
11,427 $3.68 Million
Q2 2024

Jul 09, 2024

BUY
$262.75 - $319.31 $5,780 - $7,024
22 Added 0.19%
11,373 $3.55 Million
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $464,876 - $561,164
1,729 Added 17.97%
11,351 $3.23 Million
Q4 2023

Jan 08, 2024

SELL
$255.7 - $288.46 $3,324 - $3,749
-13 Reduced 0.13%
9,622 $2.77 Million
Q1 2023

Apr 26, 2023

BUY
$225.79 - $275.2 $2.18 Million - $2.65 Million
9,635 New
9,635 $2.33 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Harbor Capital Advisors, Inc. Portfolio

Follow Harbor Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.